位置:首页 > 蛋白库 > SRSF2_PANTR
SRSF2_PANTR
ID   SRSF2_PANTR             Reviewed;         221 AA.
AC   Q5R1W5;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 98.
DE   RecName: Full=Serine/arginine-rich splicing factor 2;
DE   AltName: Full=Splicing component, 35 kDa;
DE   AltName: Full=Splicing factor SC35;
DE            Short=SC-35;
DE   AltName: Full=Splicing factor, arginine/serine-rich 2;
GN   Name=SRSF2; Synonyms=SFRS2;
OS   Pan troglodytes (Chimpanzee).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Pan.
OX   NCBI_TaxID=9598;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skin;
RA   Hirai M., Sakate R., Hida M., Sugano S., Hayasaka I., Suto Y., Osada N.,
RA   Hashimoto K.;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Necessary for the splicing of pre-mRNA. It is required for
CC       formation of the earliest ATP-dependent splicing complex and interacts
CC       with spliceosomal components bound to both the 5'- and 3'-splice sites
CC       during spliceosome assembly. It also is required for ATP-dependent
CC       interactions of both U1 and U2 snRNPs with pre-mRNA. Interacts with
CC       other spliceosomal components, via the RS domains, to form a bridge
CC       between the 5'- and 3'-splice site binding components, U1 snRNP and
CC       U2AF. Binds to purine-rich RNA sequences, either 5'-AGSAGAGTA-3' (S=C
CC       or G) or 5'-GTTCGAGTA-3'. Can bind to beta-globin mRNA and commit it to
CC       the splicing pathway. The phosphorylated form (by SRPK2) is required
CC       for cellular apoptosis in response to cisplatin treatment (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: In vitro, self-associates and binds SRSF1/SFRS1 (ASF/SF2),
CC       SNRP70 and U2AF1 but not U2AF2. Binds SREK1/SFRS12. Interacts with
CC       CCNL1 and CCNL2. Interacts with SCAF11. Interacts with ZRSR2/U2AF1-RS2.
CC       Interacts with CCDC55 (via C-terminus). Interacts with BRDT (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus, nucleoplasm
CC       {ECO:0000250}. Nucleus speckle {ECO:0000250}. Note=Phosphorylation by
CC       SRPK2 provokes its redistribution from the nuclear speckle to
CC       nucleoplasm. {ECO:0000250}.
CC   -!- PTM: Extensively phosphorylated on serine residues in the RS domain.
CC       Phosphorylated by SRPK2 and this causes its redistribution from the
CC       nuclear speckle to nucleoplasm and controls cell fate decision in
CC       response to cisplatin treatment. KAT5/TIP60 inhibits its
CC       phosphorylation by preventing SRPK2 nuclear translocation (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Acetylation on Lys-52 by KAT5/TIP60 promotes its proteasomal
CC       degradation. This effect is counterbalanced by HDAC6, which positively
CC       controls SRSF2 protein level by deacetylating it and preventing its
CC       proteasomal degradation (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the splicing factor SR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB188282; BAD74033.1; -; mRNA.
DR   RefSeq; NP_001029290.1; NM_001034118.1.
DR   AlphaFoldDB; Q5R1W5; -.
DR   BMRB; Q5R1W5; -.
DR   SMR; Q5R1W5; -.
DR   STRING; 9598.ENSPTRP00000043428; -.
DR   PaxDb; Q5R1W5; -.
DR   PRIDE; Q5R1W5; -.
DR   GeneID; 619467; -.
DR   KEGG; ptr:619467; -.
DR   CTD; 6427; -.
DR   eggNOG; KOG4207; Eukaryota.
DR   InParanoid; Q5R1W5; -.
DR   OrthoDB; 1524134at2759; -.
DR   Proteomes; UP000002277; Unplaced.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IEA:InterPro.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR003954; RRM_dom_euk.
DR   InterPro; IPR034893; SRSF2-like.
DR   PANTHER; PTHR23147:SF119; PTHR23147:SF119; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00361; RRM_1; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   CHAIN           2..221
FT                   /note="Serine/arginine-rich splicing factor 2"
FT                   /id="PRO_0000081920"
FT   DOMAIN          14..92
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          92..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        118..187
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        192..212
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         22
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         25
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         52
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         189
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         191
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         204
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01130"
SQ   SEQUENCE   221 AA;  25487 MW;  68121772D355796A CRC64;
     MSYGRPPPDV EGMTSLKVDN LTYRTSPDTL RRVFEKYGRV GDVYIPRDRY TKESRGFAFV
     RFHDKRDAED AMDAMDGAVL DGRELRVQMA RYGRPPDSHH SRRGPPPRRY GGGGYGRRSR
     SPRRRRRSRS RSRSRSRSRS RSRYSRSKSR SRTRSRSRST SKSRSARRSK SKSSSVSRSR
     SRSRSRSRSR SPPPVSKREP KSRSRSKSPP ESPEEEGAVS S
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024